Boston Advisors’s Coherus Oncology CHRS Stock Holding History

Boston Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.24M	Buy
2019 Q2	$838K	Sell
2019 Q1	$807K	Buy
2018 Q4	$299K	Buy
2018 Q3	$484K	Sell
2018 Q2	$413K	Buy
2017 Q3	–	Sell
2017 Q2	$244K	Buy